B03XA01|Erythropoietin/Epoetin beta/|BH049|NEORECORMON|solution for injection, pre-filled syringe|10000|IU|6|60000|Roche Registration GmbH, Германия|502.78|2|1|0|C|8|5||0|0.008138| B03XA01|Erythropoietine /human recombinant|BH050|Binocrit|SOL. INJ. PRE-FILLED SYRINGE|10000 IU|IU|6|60000|Sandoz GmbH, Австрия|502.78|2|1|0|C|8|5||0|0.00838| B02BX04|ROMIPLOSTIM|BH055|NPLATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250 mcg|mcg|1|250|Amgen Europe B.V., Нидерландия|1198.85|3|1|0|C|1|||0|4.81324| B03XA01|Erythropoietine /human recombinant|BH056|Retacrit|SOL. INJ. PRE-FILLED SYRINGE|10000 IU|IU|6|60000|Pfizer Europe MA EEIG, Белгия|502.78|2|1|0|C|8|5||0|0.00837| B03XA02|DARBEPOETIN ALFA|BH057|Aranesp|SOLUTION FOR INJECTION PREFILLED SYRINGE WITH NEEDLE GUARD|300 mcg/0,6 ml|mcg|1|300|Amgen Europe B.V., Нидерландия|800.04|3|1|0|C|8|5||0|2.866| B03XA02|DARBEPOETIN ALFA|BH058|Aranesp|SOLUTION FOR INJECTION PREFILLED SYRINGE WITH NEEDLE GUARD|150 mcg/0,3 ml|mcg|1|150|Amgen Europe B.V., Нидерландия|399.96|3|1|0|C|8|5||0|2.866| B03XA03|METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA|BH081|MIRCERA|SOL. INJ. PRE-FILLED SYRINGE|150 mcg/0,3 ml|mcg|1|150|Roche Registration GmbH, Германия|450|3|1|0|C||5||0|3.09288| B02BX05|ELTROMBOPAG|BH085|Revolade|TABL. FILM. COAT.|25 mg|mg|28|700|Novartis Europharm Ltd., Ирландия|1842.86|4|0|0|C|3|||0|2.587151| B02BB01|HUMAN FIBRINOGEN|BH087|Haemocomplettan P|POWD.FOR SOL. FOR INJ/INF|1 000 mg|mg|1|1000|CSL Behring GmbH, Германия|713.18||||H|||||0.71316| B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH088|OCTAPLEX|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|356.57||||H|||||0.71313| B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH089|Prothromplex Total NF|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|600IU|IU|1|600|Baxalta Innovations GmbH, Австрия|427.88||||H|||||0.71313| B02BD02|COAGULATION FACTOR VIII|BH090|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|1000IU|IU|1|1000|CSL Behring GmbH, Германия|617.42||||H|||||0.393247| B02BD02|COAGULATION FACTOR VIII|BH091|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|250IU|IU|1|250|CSL Behring GmbH, Германия|154.36||||H|||||0.393247| B02BD02|COAGULATION FACTOR VIII|BH092|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|500IU|IU|1|500|CSL Behring GmbH, Германия|308.71||||H|||||0.393247| B02BD02|COAGULATION FACTOR VIII|BH093|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Instituto Grifols S.A., Испания|308.71||||H|||||0.393247| B02BD02|COAGULATION FACTOR VIII|BH094|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Instituto Grifols S.A., Испания|154.36||||H|||||0.393247| B02BD02|COAGULATION FACTOR VIII|BH095|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Instituto Grifols S.A., Испания|617.42||||H|||||0.393247| B02BD02|COAGULATION FACTOR VIII|BH096|Immunate|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Baxalta Innovations GmbH, Австрия|308.71||||H|||||0.393247| B02BD02|COAGULATION FACTOR VIII|BH097|OCTANATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|308.71||||H|||||0.393247| B02BD02|COAGULATION FACTOR VIII|BH098|OCTANATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Octapharma (IP) SPRL, Белгия|617.42||||H|||||0.393247| B02BD02|COAGULATION FACTOR VIII|BH099|Advate|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Baxter AG, Австрия|533.75||||H|||||1.225931| B02BD02|COAGULATION FACTOR VIII|BH100|Advate 500 IU|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Baxter AG, Австрия|533.75||||H|||||1.225931| B02BD02|COAGULATION FACTOR VIII|BH103|Kovaltry|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Bayer AG, Германия|533.75||||H|||||1.225931| B02BD02|COAGULATION FACTOR VIII|BH104|NovoEight|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A.S., Дания|533.75||||H|||||1.226544| B02BD02|COAGULATION FACTOR VIII|BH105|Nuwiq|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma AB, Швеция|533.75||||H|||||1.22708| B02BD02|COAGULATION FACTOR VIII|BH106|ReFacto AF|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Pfizer Europe MA EEIG, Белгия|533.75||||H|||||1.22708| B02BD02|COAGULATION FACTOR VIII|BH108|Adynovi|POWDER AND SOLVENT FOR INJECTION|500IU|IU|1|500|Baxalta Innovations GmbH, Австрия|664.18||||H|||||1.473743| B02BD02|COAGULATION FACTOR VIII|BH109|Adynovi|POWDER AND SOLVENT FOR INJECTION|1000IU|IU|1|1000|Baxalta Innovations GmbH, Австрия|1328.36||||H|||||1.473743| B02BD02|COAGULATION FACTOR VIII|BH110|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Swedish Orphan Biovitrum AB, Швеция|1328.36||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH111|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Swedish Orphan Biovitrum AB, Швеция|332.09||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH112|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Swedish Orphan Biovitrum AB, Швеция|664.18||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH113|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|3000 IU|IU|1|3000|Swedish Orphan Biovitrum AB, Швеция|3985.08||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH114|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2000 IU|IU|1|2000|Swedish Orphan Biovitrum AB, Швеция|2656.72||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH115|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1500 IU|IU|1|1500|Swedish Orphan Biovitrum AB, Швеция|1992.54||||H|||||| B02BD03|FACTOR VIII INHIBITOR BYPASSING ACTIVITY|BH116|Feiba|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|25 U/ml (500 U)|IU|1|500|Baxalta Innovations GmbH, Австрия|752.57||||H|||||1.50514| B02BD04|COAGULATION FACTOR IX|BH118|Aimafix|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|500IU|IU|1|500|Kedrion S.p.A., Италия|405.7||||H|||||0.577193| B02BD04|COAGULATION FACTOR IX|BH119|IMMUNINE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION/INFUSION|600IU|IU|1|600|Baxalta Innovations GmbH, Австрия|486.84||||H|||||0.577193| B02BD04|COAGULATION FACTOR IX|BH120|OCTANINE F 500|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|405.7||||H|||||0.577193| B02BD04|COAGULATION FACTOR IX|BH121|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Swedish Orphan Biovitrum AB, Швеция|2198.54||||H|||||0.577193| B02BD04|COAGULATION FACTOR IX|BH122|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|3000 IU|IU|1|3000|Swedish Orphan Biovitrum AB, Швеция|6595.61||||H|||||0.577193| B02BD04|COAGULATION FACTOR IX|BH123|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2000 IU|IU|1|2000|Swedish Orphan Biovitrum AB, Швеция|4397.08||||H|||||0.577193| B02BD04|COAGULATION FACTOR IX|BH124|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Swedish Orphan Biovitrum AB, Швеция|1099.27||||H|||||0.577193| B02BD04|COAGULATION FACTOR IX|BH125|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Swedish Orphan Biovitrum AB, Швеция|549.64||||H|||||0.577193| B02BD04|COAGULATION FACTOR IX|BH126|BeneFIX|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Pfizer Europe MA EEIG, Белгия|557.14||||H|||||1.115395| B02BD06|VON WILLEBRAND FACTOR AND COAG FACTORVIII IN COMB|BH127|Wilate 500|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, Белгия|471.14||||H|||||0.934802| B02BD08|EPTACOG ALFA (ACTIVATED)|BH128|NovoSeven|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2 mg (100 KIU)|MG|1|2|Novo Nordisk A.S., Дания|2362.2||||H|||||1180.8| B02BD08|EPTACOG ALFA (ACTIVATED)|BH129|NovoSeven|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|5 mg (250 KIU)|MG|1|5|Novo Nordisk A.S., Дания|5905.5||||H|||||1180.8| B02BD02|COAGULATION FACTOR VIII|BH130|Jivi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Bayer AG, Германия|664.18||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH131|Jivi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000 IU|IU|1|1000|Bayer AG, Германия|1328.36||||H|||||| B02BD04|COAGULATION FACTOR IX|BH132|Refixia|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A/S, Дания|1099.27||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH133|Esperoct|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A/S, Дания|664.18||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH134|Esperoct|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Novo Nordisk A/S, Дания|1328.36||||H|||||| B02BB01|HUMAN FIBRINOGEN|BH135|Fibryga|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION/INFUSION|1000 mg|mg|1|1000|Octapharma (IP) SPRL, Белгия|713.18||||H|||||0.71316| B02BD02|COAGULATION FACTOR VIII|BH136|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000 IU|IU|1|1000|CSL Behring GmbH, Германия|1067.5||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH137|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|CSL Behring GmbH, Германия|266.88||||H|||||| B02BD02|COAGULATION FACTOR VIII|BH138|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|CSL Behring GmbH, Германия|533.75||||H|||||| H02AB02|Dexamethasone|HH003|Dexamethasone Sopharma|SOLUTION FOR INJECTION|4 mg/ml - 2ml|mg|10|80|Софарма АД, България|15.7|1|0|0|C|2|7||0|0.087017| H02AB02|Dexamethasone|HH005|Dexamethasone Sopharma|SOLUTION FOR INJECTION|4 mg/ml - 1 ml|mg|10|40|Софарма АД, България|7.85|1|0|0|C|2|7||0|0.087017| H02AB02|Dexamethasone|HH006|Dexamethasone KRKA|SOLUTION FOR INJECTION|4 mg/ml - 1 ml|mg|25|100|KRKA d.d., Словения|19.63|1|0|0|C|2|7||0|0.087017| H01CB02|OCTREOTIDE|HH007|Sandostatin LAR|POWD.AND SOLVENT FOR SUSP. INJ.|20 mg|mg|1|20|Novartis Pharma GmbH, Германия|659.45|2|1|0|C|7|2||0|36.781573| H01CB02|OCTREOTIDE|HH008|Sandostatin LAR|POWD. FOR SOL. FOR INFUSION|30 mg|mg|1|30|Novartis Pharma GmbH, Германия|989.29|2|1|0|C|7|2||0|36.781573| L01DB03|Epirubicin|LH004|Farmorubicin PFS|sol. for inj.|2 mg/ml - 25 ml|mg|1|50|Pfizer Europe MA EEIG, Белгия|43.33|1|4|0|C||1||1|0.863568| L01BC01|Cytarabine|LH005|ALEXAN|solution for injection|50 mg/ ml - 20 ml|mg|1|1000|Ebewe Pharma GmbH. N.fg. KG, Австрия|21.44|1|4|0|C||1||1|0.021439| L01DB03|Epirubicin|LH015|"EPIRUBICIN ""EBEWE"""|concentrate for solution for injection/ infusion|2 mg/ml- 25 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, Австрия|43.33|1|4|0|C||1||1|0.863568| L01CD01|Paclitaxel|LH017|Sindaxel|Concentrate for solution for infusion|6 mg/ml - 50 ml|mg|1|300|Актавис ЕАД, България|66.05|1|4|0|C||1||1|0.200194| L01DB03|Epirubicin|LH024|EPISINDAN|solution for infusion|2 mg/ml - 50 ml|mg|1|100|Actavis Group PTC ehf., Исландия|86.66|1|4|0|C||1||1|0.863568| L01CD01|Paclitaxel|LH030|"Paclitaxel ""Ebewe"""|concentrate for solution for infusion|6 mg/ml - 16,7 ml|mg|1|100.2|Ebewe Pharma GmbH. N.fg. KG, Австрия|22.02|1|4|0|C||1||1|0.200194| L01CD01|PACLITAXEL|LH046|Paclitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 50 ml|mg|1|300|Accord Healthcare Polska , Полша|66.05|1|4|0|C||1||1|0.200194| L01DB06|Idarubicin|LH047|ZAVEDOS|powder for sol. for inf.|5 mg|mg|1|5|Pfizer Enterprises S.A.R.L., Люксембург|53.88|1|4|0|C||1||1|10.690476| L01DB06|Idarubicin|LH065|ZAVEDOS|powder for sol. for inf.|10 mg|mg|1|10|Pfizer Enterprises S.A.R.L., Люксембург|107.76|1|4|0|C||1||1|10.690476| L01DB07|Mitoxantrone|LH075|MITOXANTRON EBEWE|concentrate for solution for infusion|2 mg/ml - 10 ml|mg|1|20|Ebewe Pharma GmbH. N.fg. KG, Австрия|67.69|1|4|0|C|7|1||1|3.12| L01CA04|VINORELBINE|LH078|Vinorelbin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 5 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, Австрия|68.36|1|4|0|C|8|1||1|1.361837| L01XA01|CISPLATIN|LH109|Cisplatin Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg/ml - 50 ml|mg|1|50|Accord Healthcare Polska , Полша|10.72|1|4|0|C||1||1|0.21408| L01XA02|Carboplatin|LH113|CARBOPLATIN EBEWE|Concentrate for solution for infusion|10 mg/ml-15 ml|mg|1|150|Ebewe Pharma GmbH. N.fg. KG, Австрия|22.39|1|4|0|C||1||1|0.147925| L01BB06|Clofarabine|LH117|EVOLTRA|concentrate for sol. for inf.|1 mg/ml - 20 ml|mg|1|20|Genzyme Europe B.V., Нидерландия|1311.18|1|4|0|C||1||1|54.020108| L03AA02|FILGRASTIM|LH123|Nivestim|SOL. FOR INJ/INF IN PRE-FILLED SYRINGE|30 MIU/0.5 ml|mcg|5|1500|Pfizer Europe MA EEIG, Белгия|113.82|3|1|0|C|7|5||0|0.1024| L01XA02|Carboplatin|LH127|Carboplatin Actavis|concentrate for solution for infusion|10 mg/ml - 15 ml|mg|1|150|Actavis Group PTC ehf., Исландия|22.39|1|4|0|C||1||1|0.147925| L03AA02|Filgrastim|LH128|Zarzio|solution for injection/infusion|30 MU/ 0,5 ml|mcg|5|1500|Sandoz GmbH, Австрия|113.82|3|1|0|C|7|5||0|0.1024| L01XE07|Lapatinib|LH137|TYVERB|film-coated tablets, bottle|250|mg|140|35000|Novartis Europharm Ltd., Ирландия|3697.04|4|0|0|C|3|3||0|0.11295| L01XE08|Nilotinib|LH139|Tasigna|hard capsules|200|mg|28|5600|Novartis Europharm Ltd., Ирландия|1519.21|4|0|0|C|3|3||0|0.278234| L01XE08|Nilotinib|LH140|Tasigna|hard capsules|150|mg|28|4200|Novartis Europharm Ltd., Ирландия|1139.42|4|0|0|C|3|3||0|0.278234| L01XC02|Rituximab|LH154|MabThera|concentrate for sol. for inf.|100|mg|2|200|Roche Registration GmbH, Германия|667.58|1|4|0|C||3||1|1.949563| L01XC02|Rituximab|LH155|MabThera|concentrate for sol. for inf.|500|mg|1|500|Roche Registration GmbH, Германия|1668.94|1|4|0|C||3||1|1.949563| L01XC03|Trastuzumab|LH156|Herceptin|powder for concentrate for solution for infusion|150|mg|1|150|Roche Registration GmbH, Германия|668.22|1|4|0|C||3||1|2.36377| L01XE09|TEMSIROLIMUS|LH158|Torisel|CONCENTRATE AND SOLVENT FOR SOLUTION FOR INJ.|30 mg|mg|1|30|Pfizer Europe MA EEIG, Белгия|1570.2|1|4|0|C||3||1|52.928| L01XC06|CETUXIMAB|LH160|ERBITUX|SOL. FOR INF.|5 mg/ml - 20 ml|mg|1|100|Merck Europe B.V., Нидерландия|356.8|1|4|0|C|7|3||1|3.565549| L01XC07|Bevacizumab|LH161|Avastin|concentrate for solution for infusion|25 mg/ml-4 ml|mg|1|100|Roche Registration GmbH, Германия|365.84|1|4|0|C|8|3||1|5.09334| L01XE10|EVEROLIMUS|LH162|Afinitor|TABL|5 mg|mg|30|150|Novartis Europharm Ltd., Ирландия|1310.62|4|0|0|C|3|3||0|9.48| L01XC07|Bevacizumab|LH163|Avastin|concentrate for solution for infusion|25 mg/ml-16 ml|mg|1|400|Roche Registration GmbH, Германия|1438.13|1|4|0|C|8|3||1|5.09334| L01XE10|EVEROLIMUS|LH164|Afinitor|TABL|10 mg|mg|30|300|Novartis Europharm Ltd., Ирландия|2621.24|4|0|0|C|3|3||0|9.48| L01XC08|Panitumumab|LH165|Vectibix|concentrate for solution for infusion|20mg/ml - 5ml|mg|1|100|Amgen Europe B.V., Нидерландия|694.57|1|4|0|C|8|3||1|7.504| L01XE11|Pazopanib|LH166|VOTRIENT|film. coated tabl.|200|mg|30|6000|Novartis Europharm Ltd., Обединено Кралство|1353.66|4|0|0|C|3|3||0|0.212776| L01XE11|Pazopanib|LH170|VOTRIENT|film. coated tabl.|400|mg|60|24000|Novartis Europharm Ltd., Ирландия|5414.57|4|0|0|C|3|3||0|0.212776| L01XE04|SUNITINIB|LH172|Sutent|CAPSULE, HARD|12,5 mg|mg|30|375|Pfizer Europe MA EEIG, Белгия|1590.02|4|0|0|C|3|3||0|6.0984| L01XX17|Topotecan|LH175|Hycamtin|powd. for concentrate for sol. for inf.|4|mg|1|4|Novartis Europharm Ltd., Ирландия|74.14|1|4|0|C||1||1|15| L01XE04|SUNITINIB|LH176|Sutent|CAPSULE, HARD|25 mg|mg|30|750|Pfizer Europe MA EEIG, Белгия|3180.03|4|0|0|C|3|3||0|6.0984| L01XE04|SUNITINIB|LH177|Sutent|CAPSULE, HARD|50 mg|mg|30|1500|Pfizer Europe MA EEIG, Белгия|6360.06|4|0|0|C|3|3||0|6.0984| L01XE05|Sorafenib|LH179|Nexavar|film coated tabl.|200|mg|112|22400|Bayer AG, Германия|2649.13|4|0|0|C|3|3||0|0.288151| L01XX17|Topotecan|LH180|POTACTASOL|powder for concentrate for solution for infusion|4|mg|1|4|Actavis Group PTC ehf., Исландия|74.14|1|4|0|C||1||1|15| L01EA02|DASATINIB|LH181|Sprycel|TABL. FILM. COAT.|50 mg|mg|60|3000|Bristol-Myers Squibb Pharma EEIG, Ирландия|6468.82|4|0|0|C|3|3||0|2.156| L01XX17|Topotecan|LH184|Hycamtin|caps. hard|1|mg|10|10|Novartis Europharm Ltd., Ирландия|538.15|4|0|0|C|3|1||0|55.615| L01BA01|Methotrexate|LH187|METHOTREXATE EBEWE|concentrate for solution for infusion|100 mg/ml - 10 ml|mg|1|1000|Ebewe Pharma GmbH. N.fg. KG, Австрия|32.99|1|4|0|C||1||1|0.0312| L01XX19|Irinotecan|LH196|Irinotecan Actavis|concentrate for solution for injection|20 mg/ml - 5 ml|mg|1|100|Актавис ЕАД, България|29.88|1|3|0|C||1||1|0.222271| L01XX23|MITOTANE|LH202|Lysodren|TABL|500 mg|mg|100|50000|HRA Pharma Rare Disease|1098.47|4|0|0|C|3|1||0|| L03AX16|Plerixafor|LH218|Mozobil|solution for injection|20 mg/ml - 1,2 ml|mg|1|24|Genzyme Europe B.V., Нидерландия|11073.58|3|1|0|C||5||0|460.146367| L01BB05|Fludarabine phosphate|LH219|Fludarabine Actavis|powder for sol. for inj./inf.|50|mg|1|50|Actavis Group PTC ehf., Исландия|45.79|1|4|0|C||1||1|2.42952| L01XA03|Oxaliplatin|LH227|Oxaliplatin-Tchaikapharma|powder for solution for infusion|100|mg|1|100|Чайкафарма - Висококачествените лекарства АД, България|30.44|1|3|0|C||1||1|0.235699| L01CD02|DOCETAXEL|LH230|Docetaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|80 mg/ 4 ml|mg|1|80|Accord Healthcare S.L.U., Испания|33.24|1|2|0|C||1||1|0.293046| L01XX17|TOPOTECAN|LH233|Topotecan Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|1mg/ml - 4 ml|mg|1|4|Accord Healthcare Polska , Полша|74.14|1|4|0|C||1||1|15| L03AA13|PEGFILGRASTIM|LH234|Neulasta|SOLUTION FOR INJECTION|6 mg|mg|1|6|Amgen Europe B.V., Нидерландия|619.87|2|1|0|C|7|5||0|63.583241| L01XA03|OXALIPLATIN|LH237|OXALIPLATIN ACCORD|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|Accord Healthcare Polska , Полша|30.44|1|3|0|C||1||1|0.235699| L04AD01|Ciclosporin|LH243|Sandimmun Neoral|caps. soft|25|mg|50|1250|Novartis Pharma GmbH, Германия|30.44|4|0|0|C|3|||0|0.02568| L04AD01|Ciclosporin|LH244|Sandimmun Neoral|caps. soft|50|mg|50|2500|Novartis Pharma GmbH, Германия|60.88|4|0|0|C|3|||0|0.02568| L04AD01|Ciclosporin|LH253|Sandimmun Neoral|oral solution|100 mg/ml - 50 ml|mg|1|5000|Novartis Pharma GmbH, Германия|136.69|4|0|0|C|3|||0|0.027312| L01BC05|GEMCITABINE|LH260|GEMCITABINE ACCORD|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , Полша|39.1|1|4|0|C|8|1||1|0.031363| L01XA03|Oxaliplatin|LH261|Oxaliplatin Actavis|concentrate for solution for infusion|5 mg/ml - 20 ml|mg|1|100|Actavis Group PTC ehf., Исландия|30.44|1|3|0|C||1||1|0.235699| L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH272|Levact|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|100 mg|mg|5|500|Astellas Pharma GmbH, Германия|898.84|1|4|0|C|6|1||1|1.572068| L01AX03|Temozolomide|LH273|Blastomat|hard caps.|100|mg|5|500|Alvogen IPCo.S.a.r.l., Люксембург|95.39|4|0|0|C|3|1||0|0.154376| L01CD04|Cabazitaxel|LH274|Jevtana|concentrate and solvent for solution for infusion|60|mg|1|60|Sanofi Aventis, Франция|7493.05|1|4|0|C||1||1|124.79757| L01DB01|DOXORUBICIN|LH275|Doxorubicin Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|2 mg/ml - 25 ml|mg|1|50|Accord Healthcare Polska , Полша|16.67|1|3|0|C|7|1||1|0.33312| L01DB01|DOXORUBICIN|LH281|Myocet liposomal|POWDER, DISPERSION AND CONCENTRATE FOR DISPERSION FOR INFUSION|50 mg|mg|2|100|Teva B.V, Нидерландия|489.52|1|2|0|C|7|1||1|12.656305| L01BC01|CYTARABINE|LH288|Cytarabine Accord|SOL. FOR INJ/INF|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , Полша|29.28|1|4|0|C||1||1|0.02136| L01BC06|CAPECITABINE|LH291|Capecitabine Accord|TABL. FILM. COAT.|500 mg|mg|120|60000|Accord Healthcare S.L.U., Испания|92.58|4|0|0|C|3|1||0|0.00154| L01BC53|tegafur/gimeracil/oteracil|LH302|Teysuno|hard caps.|20 mg/5,8 mg/15,8 mg|mg|84|1680|Nordic Group BV, Холандия|631.8|4|0|0|C|3|1||0|0.376072| L01XC11|IPILIMUMAB|LH303|Yervoy|CONCENTRATE FOR SOLUTION FOR INFUSION|5 MG/ML - 40 ML|mg|1|200|Bristol-Myers Squibb Pharma EEIG, Ирландия|26333.11|1|4|0|C||4||1|132.702| L01XC11|IPILIMUMAB|LH304|Yervoy|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 10 ml|mg|1|50|Bristol-Myers Squibb Pharma EEIG, Ирландия|6583.28|1|4|0|C||4||1|132.702| L01XE15|Vemurafenib|LH305|ZELBORAF|film-coated tabl.|240|mg|56|13440|Roche Registration GmbH, Германия|2761.72|4|0|0|C|3|3||0|0.204605| L01XX41|ERIBULIN|LH306|Halaven|SOL.FOR INJ|0.44mg/ml - 1 vial x 2ml|mg|1|0.88|Eisai GmbH, Германия|721.73|1|4|0|C||1||1|825.654546| L01BC02|FLUOROURACIL|LH309|Fluorouracil Accord|SOL. FOR INJ/INF|50 mg/ml - 20 ml|mg|1|1000|Accord Healthcare Polska , Полша|5.02|1|4|0|C|8|1||1|0.004258| L01XC03|Trastuzumab|LH310|Herceptin|solution for injection|600 mg/5 ml|mg|1|600|Roche Registration GmbH, Германия|2347.97|3|2|0|C|8|3||0|4.81728| L01CD01|PACLITAXEL|LH317|Paclitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 16.7 ml|mg|1|100.2|Accord Healthcare Polska , Полша|22.02|1|4|0|C||1||1|0.200194| L01XC02|Rituximab|LH320|MabThera|sol. for inj.|1400mg/11.7 ml|mg|1|1400|Roche Registration GmbH, Германия|3293.18|3|1|0|C||3||0|2.425036| L01XX35|Anagrelide|LH321|THROMBOREDUCTIN|hard caps.|0.5|mg|100|50|AOP Orphan Pharmaceuticals AG, Австрия|228.71|4|0|0|C|3|||0|5.628799| L01XE01|Imatinib|LH324|Meaxin|film-coated tabl.|100|mg|120|12000|KRKA d.d., Словения|202.06|4|0|0|C|3|3||0|0.0101| L01DB03|Epirubicin hydrochloride|LH332|Episindan|sol. for inj.|2 mg/ml - 25 ml|mg|1|50|Actavis Group PTC ehf., Исландия|43.33|1|4|0|C||1||1|0.863568| L01XC12|Brentuximab vedotin|LH334|Adcetris|powder for concentrate for sol. for inf.|50|mg|1|50|Takeda Pharma A/S, Дания|6427.98|1|3|0|C||3||1|129.448883| L01XC13|Pertuzumab|LH335|Perjeta|concentrate for solution for infusion|420|mg|1|420|Roche Registration GmbH, Германия|5223.79|1|2|0|C|8|3||0|13.180885| L01XE13|Afatinib|LH336|Giotrif|film-coated tablets|30|mg|28|840|Boehringer Ingelheim International GmbH, Германия|2787.37|4|0|0|C|3|3||0|3.325715| L01XE13|Afatinib|LH337|Giotrif|film-coated tablets|40|mg|28|1120|Boehringer Ingelheim International GmbH, Германия|3716.5|4|0|0|C|3|3||0|3.325715| L01XE16|Crizotinib|LH338|Xalkori|hard capsules|250|mg|60|15000|Pfizer Europe MA EEIG, Белгия|9845.09|4|0|0|C|3|3||0|0.651976| L01XE17|Axitinib|LH339|Inlyta|film. coated tabl.|5|mg|56|280|Pfizer Limited, Обединено Кралство|6790.03|4|0|0|C|3|3||0|25.367143| L01XE18|Ruxolitinib|LH340|Jakavi|tabl.|5|mg|56|280|Novartis Europharm Ltd., Ирландия|3434.06|4|0|0|C|3|3||0|12.123857| L01XX44|Aflibercept|LH341|Zaltrap|concentrate for sol. for inf.|25 mg/ml - 8 ml|mg|1|200|Sanofi Aventis Groupe, Франция|1233.85|1|3|0|C|8|3||1|6.840354| L01XX44|Aflibercept|LH342|Zaltrap|concentrate for sol. for inf.|25 mg/ml - 4 ml|mg|1|100|Sanofi Aventis Groupe, Франция|616.93|1|3|0|C|8|3||1|6.840354| L02BB04|Enzalutamide|LH343|Xtandi|soft capsules|40|mg|112|4480|Astellas Pharma Europe B.V., Нидерландия|5869.04|4|0|0|C|3|2||0|1.36933| L03AA14|LIPEGFILGRASTIM|LH344|LONQUEX|SOL. INJ. PRE-FILLED SYRINGE|6mg/0.6ml|mg|1|6|Teva B.V, Нидерландия|1035.68|3|1|0|C|7|5||0|195.662119| L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH348|Bendamustine Actavis|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|100 mg|mg|1|100|Actavis Group PTC ehf., Исландия|179.77|1|4|0|C|6|1||1|1.572068| L01XX32|BORTEZOMIB|LH349|Vortemyel|POWDER FOR SOLUTION FOR INJECTION|3.5 mg|mg|1|3.5|Алвоген Фарма Трейдинг Юръп ЕООД, България|150|1|4|0|C||3||1|22.607572| L01XX32|Bortezomib|LH354|Bortezomib Actavis|powd. for sol. for inj.|3.5|mg|1|3.5|Actavis Group PTC ehf., Исландия|150|1|4|0|C||3||1|22.607572| L01BC07|AZACITIDINE|LH355|Vidaza|POWD.SUSP|25mg/ml|mg|1|100|Celgene Europe B.V. Нидерландия|207.48|3|1|0|C||1||1|7.2228| L01XC14|Trastuzumab emtansine|LH358|Kadcyla|powder for concentrate for sol. for inf.|100 mg/5 ml|mg|1|100|Roche Registration GmbH, Германия|3445.92|1|2|0|C||3||1|35.451676| L01XC14|Trastuzumab emtansine|LH359|Kadcyla|powder for concentrate for solution for infusion|160 mg/8 ml|mg|1|160|Roche Registration GmbH, Германия|5180.27|1|2|0|C||3||1|35.451676| L01XE12|Vandetanib|LH360|Caprelsa|film-coated tabl.|100|mg|30|3000|Genzyme Europe B.V., Нидерландия|3062.82|4|0|0|C|3|3||0|1.03956| L01XE12|Vandetanib|LH361|Caprelsa|film-coated tabl.|300|mg|30|9000|Genzyme Europe B.V., Нидерландия|9188.45|4|0|0|C|3|3||0|1.03956| L01XE14|Bosutinib|LH362|Bosulif|film-coated tabl.|100|mg|28|2800|Pfizer Limited, Обединено Кралство|1271.04|4|0|0|C|3|3||0|0.46314| L01XE14|Bosutinib|LH363|Bosulif|film-coated tabl.|500|mg|28|14000|Pfizer Limited, Обединено Кралство|6355.22|4|0|0|C|3|3||0|0.46314| L01XE23|Dabrafenib|LH364|Tafinlar|caps. hard|75|mg|120|9000|Novartis Europharm Ltd., Ирландия|11194.38|4|0|0|C|3|3||0|1.2892| L01XX43|Vismodegib|LH365|Erivedge|caps. hard|150|mg|28|4200|Roche Registration GmbH, Германия|9685.33|4|0|0|C|3|3||0|2.315702| L01AA02|CHLORAMBUCIL|LH366|Leukeran|TABL. FILM. COAT.|2 mg|mg|25|50|Aspen Pharma Trading Ltd., Ирландия|24.83|4|0|0|C|3|1||0|0.4966| L01BA04|PEMETREXED|LH367|Pemetrexed Sandoz|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|500 mg|mg|1|500|Sandoz GmbH, Австрия|1063.03|1|2|0|C|7|1||1|0.2046| L01BB02|MERCAPTOPURINE|LH368|Puri-Nethol|TABL|50 mg|mg|25|1250|Aspen Pharma Trading Ltd., Ирландия|31.55|4|0|0|C|3|1||0|0.03778| L01XC21|Ramucirumab|LH370|Cyramza|concentrate for sol. for inf.|10 mg/ml – 10 ml|mg|2|200|Eli Lilly Nederland B.V., Нидерландия|1607.95|1|3|0|C||3||1|7.89378| L01BA04|PEMETREXED|LH372|Pemetrexed Alvogen|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|500 mg|mg|1|500|Alvogen IPCo.S.a.r.l., Люксембург|1063.03|1|2|0|C|7|1||1|0.2046| L01BA04|PEMETREXED|LH375|Armisarte|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 20 ml|mg|1|500|Actavis Group PTC ehf., Исландия|1063.03|1|2|0|C|7|1||1|0.2046| L01BA04|PEMETREXED|LH376|Armisarte|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 40 ml|mg|1|1000|Actavis Group PTC ehf., Исландия|2126.06|1|2|0|C|7|1||1|0.2046| L01AX03|TEMOZOLOMIDE|LH379|Temozolomide Accord|CAPSULE, HARD|100 mg|mg|5|500|Accord Healthcare S.L.U., Испания|95.39|4|0|0|C|3|1||0|0.154376| L01XX32|BORTEZOMIB|LH380|Bortezomib Accord|POWDER FOR SOLUTION FOR INJECTION|3.5 mg|mg|1|3.5|Accord Healthcare S.L.U., Испания|150|1|4|0|C||3||1|22.607572| L01BC02|FLUOROURACIL|LH382|5-Fluorouracil Ebewe|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|50 mg/ml - 20 ml|mg|10|10000|Ebewe Pharma GmbH. N.fg. KG, Австрия|50.2|1|4|0|C|8|1||1|0.004258| L01CD02|Docetaxel|LH383|DOCETAXEL ACTAVIS|Concentrate for sol. for inf.|20 mg/ml- 8 ml|mg|1|160|Actavis Group PTC ehf., Исландия|66.47|1|2|0|C||1||1|0.293046| L03AX03|Mycobacterium bovis BCG|LH386|CALGEVAX|Powder for suspension|11.25|mg|4|45|БУЛ БИО-НЦЗПБ ЕООД, България|165.34|1|4|0|C|6|4||0|3.306667| L01BA04|PEMETREXED|LH387|Pemetrexed Accord|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|500 mg|mg|1|500|Accord Healthcare S.L.U., Испания|1063.03|1|2|0|C|7|1||1|0.2046| L01BC05|Gemcitabine|LH388|Gemcitabine Actavis|Concentrate for solution for infusion|40 mg/ml – 25 ml|mg|1|1000|Actavis Group PTC ehf., Исландия|39.1|1|4|0|C|8|1||1|0.031363| L01EL01|IBRUTINIB|LH390|Imbruvica|CAPSULE, HARD|140|mg|90|12600|Janssen-Cilag International N.V., Белгия|11463.67|4|0|0|C|3|3||0|0.962896| L01XX46|Olaparib|LH391|Lynparza|Capsule, hard|50|mg|448|22400|Astra Zeneca AB, Швеция|9911.48|4|0|0|C|3|3||0|0.460162| L01XE17|Axitinib|LH393|Inlyta|film coated tabl.|1|mg|56|56|Pfizer Limited, Обединено Кралство|1358.01|4|0|0|C|3|3||0|25.367143| L01XE03|ERLOTINIB|LH394|Varlota|TABL. FILM. COAT.|100 mg|mg|30|3000|Алвоген Фарма Трейдинг Юръп ЕООД, България|764.95|4|0|0|C|3|3||0|0.055206| L01XE03|ERLOTINIB|LH395|Varlota|TABL. FILM. COAT.|150 mg|mg|30|4500|Алвоген Фарма Трейдинг Юръп ЕООД, България|1147.43|4|0|0|C|3|3||0|0.055206| L01XC18|Рembrolizumab|LH399|Keytruda|Concentrate for solution for infusion|25 mg/ml - 4 ml|mg|1|100|Merck Sharp & Dohme Ltd., Обединено Кралство|5957.79|1|2|0|C||4||0|59.996899| L01XE01|Imatinib|LH401|Imatinib Teva Pharma|Film coated tablet|100|mg|120|12000|Тева Фармасютикълс България ЕООД, България|202.06|4|0|0|C|3|3||0|0.0129| L01XE01|Imatinib|LH402|Imatinib Teva Pharma|Film coated tablet|100|mg|120|12000|Тева Фармасютикълс България ЕООД, България|202.06|4|0|0|C|3|3||0|0.0101| L01XE01|IMATINIB|LH403|Nibix|CAPSULE, HARD|100 mg|mg|120|12000|Adamed Pharma S.A., Полша|202.06|4|0|0|C|3|3||0|0.0101| L01XE03|Erlotinib|LH404|Erlotinib Sandoz|Film coated tablet|100|mg|30|3000|Sandoz d.d., Словения|764.95|4|0|0|C|3|3||0|0.055206| L01XE03|Erlotinib|LH405|Erlotinib Actavis|Film coated tablet|100|mg|30|3000|Actavis Group PTC ehf., Исландия|764.95|4|0|0|C|3|3||0|0.055206| L01XE03|Erlotinib|LH406|Erlotinib Actavis|Film coated tablet|150|mg|30|4500|Actavis Group PTC ehf., Исландия|1147.43|4|0|0|C|3|3||0|0.055206| L01DB11|PIXANTRONE|LH408|Pixuvri|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|29mg|mg|1|29|Les Laboratoires Servier, Франция|988.12|1|4|0|C||1||1|33.302789| L01XC15|Obinutuzumab|LH409|Gazyvaro|Concentrate for solution for infusion|1000 mg - 40 ml|mg|1|1000|Roche Registration GmbH, Германия|6583.58|1|4|0|C||3||1|6.572711| L01XC17|NIVOLUMAB|LH410|Opdivo|CONCENTRATE FOR SOLUTION FOR INFUSION|10 MG/ML - 10 ML|mg|1|100|Bristol-Myers Squibb Pharma EEIG, Ирландия|2388.48|1|2|0|C||4||1|23.88018| L01XC17|NIVOLUMAB|LH411|Opdivo|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml-4ml|mg|1|40|Bristol-Myers Squibb Pharma EEIG, Ирландия|955.39|1|2|0|C||4||1|23.88018| L01XC19|blinatumomab|LH412|Blincyto|powder for concentrate and solution for solution for infusion|38.5|mcg|1|38.5|Amgen Europe B.V., Нидерландия|4946.8|1|2|0|C||3||1|135.394285| L01XE21|Regorafenib|LH414|Stivarga|Film coated tablet|40|mg|84|3360|Bayer AG, Германия|5048.84|4|0|0|C|3|3||0|1.474068| L01XE24|Ponatinib|LH415|Iclusig|Film coated tablet|15|mg|60|900|Incyte Biosciences Distribution B.V., Нидерландия|12613.02|4|0|0|C|3|3||0|13.932| L01XE33|palbociclib|LH416|Ibrance|Capsule, hard|75|mg|21|1575|Pfizer Limited, Обединено Кралство|2769.43|4|0|0|C|3|3||0|1.9552| L01XE33|palbociclib|LH417|Ibrance|Capsule, hard|100|mg|21|2100|Pfizer Limited, Обединено Кралство|3692.58|4|0|0|C|3|3||0|1.9552| L01XE33|palbociclib|LH418|Ibrance|Capsule, hard|125|mg|21|2625|Pfizer Limited, Обединено Кралство|4615.73|4|0|0|C|3|3||0|1.9552| L01XE35|Osimertinib|LH419|Tagrisso|Film coated tablet|40|mg|28|1120|Astra Zeneca AB, Швеция|6305.34|4|0|0|C|3|3||0|5.852146| L01XE35|Osimertinib|LH420|Tagrisso|Film coated tablet|80|mg|28|2240|Astra Zeneca AB, Швеция|12610.69|4|0|0|C|3|3||0|5.852146| L01XX45|Carfilzomib|LH421|Kyprolis|Powder for solution for infusion|60|mg|1|60|Amgen Europe B.V., Нидерландия|2211.84|1|4|0|C||3||1|37.126| L01XX52|venetoclax|LH426|Venclyxto|Film coated tablet|100|mg|112|11200|AbbVie Deutchland GmbH & Co. KG, Германия|11343.58|4|0|0|C|3|3||0|1.070897| L01XE03|Erlotinib|LH427|Erlotinib Sandoz|Film coated tablet|150|mg|30|4500|Sandoz d.d., Словения|1147.43|4|0|0|C|3|3||0|0.055206| L01AA01|Cyclophosphamide|LH430|Endoxan|Powder for solution for injection|500|mg|1|500|Екофарм Груп АД, България|26.36|1|4|0|C|7|1||1|0.05272| L01XX32|Bortezomib|LH432|Bortezocon|Powder for solution for injection|3.5|mg|1|3.5|Фармаконс АД, България|150|1|4|0|C||3||1|22.607572| L01AA06|Ifosfamide|LH433|Holoxan|Powder for solution for infusion|2000|mg|1|2000|Екофарм Груп АД, България|188.84|1|4|0|C||1||1|0.09442| L01XA03|Oxaliplatin|LH435|Oxaliplatin Bulgermed VE|Concentrate for solution for infusion|5 mg/ml - 20 ml|mg|1|100|Булгермед ВЕ ООД, България|30.44|1|3|0|C||1||1|0.235699| L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH438|Bendamustine Mylan|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|2 mg/ml - 50 ml|mg|5|500|Mylan S.A.S., Франция|898.84|1|4|0|C|6|1||1|1.572068| L01BB06|CLOFARABINE|LH439|Clofarabin Alvogen|CONCENTRATE FOR SOLUTION FOR INFUSION|1mg/ml - 20ml|mg|1|20|Alvogen Malta Operations (ROW) Ltd., Малта|1311.18|1|4|0|C||1||1|54.020108| L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH440|Bendamustine Accord|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|100 mg|mg|5|500|Accord Healthcare Polska , Полша|898.84|1|4|0|C|6|1||1|1.572068| L03AA02|FILGRASTIM|LH442|Accofil|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|30 MU (300 mcg/0.5 ml)|mcg|5|1500|Accord Healthcare S.L.U., Испания|113.82|3|1|0|C|7|5||0|0.1024| L01BA01|METHOTREXATE|LH443|Methotrexate Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , Полша|32.99|1|4|0|C||1||1|0.0312| L01XC03|Trastuzumab|LH444|Kanjinti|Powder for concentrate for solution for infusion|150|mg|1|150|Amgen Europe B.V., Нидерландия|668.22|1|4|0|C||3||1|2.36377| L01XC03|Trastuzumab|LH445|Kanjinti|Powder for concentrate for solution for infusion|420|mg|1|420|Amgen Europe B.V., Нидерландия|1871.02|1|4|0|C||3||1|2.36377| L01XX19|IRINOTECAN|LH446|Irinotecan Accord|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Accord Healthcare Polska , Полша|29.88|1|3|0|C||1||1|0.222271| L02BX03|ABIRATERONE ACETATE|LH447|Zytiga|TABLETS FILM COATED|500 mg|mg|60|30000|Janssen-Cilag International N.V., Белгия|6232.76|4|0|0|C|3|2||0|0.207758| L01CB01|ETOPOSIDE|LH450|Etoposide Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Accord Healthcare Polska , Полша|12.64|1|4|0|C||1||1|0.126| L01XC02|Rituximab|LH454|Rixathon|Concentrate for solution for infusion|100 mg/10 ml|mg|2|200|Sandoz GmbH, Австрия|667.58|1|4|0|C||3||1|1.949563| L01XC02|Rituximab|LH455|Rixathon|Concentrate for solution for infusion|500 mg/50 ml|mg|1|500|Sandoz GmbH, Австрия|1668.94|1|4|0|C||3||1|1.949563| L01CD01|PACLITAXEL|LH456|Paclitaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 50 ml|mg|1|300|Булгермед ВЕ ООД, България|66.05|1|4|0|C||1||1|0.200194| L01XX32|Bortezomib|LH457|Bortezomib Sandoz|Powder for solution for injection|3.5|mg|1|3.5|Sandoz d.d., Словения|150|1|4|0|C||3||1|22.607572| L01XC02|Rituximab|LH458|MabThera|Solution for injection|1600 mg/13.4 ml|mg|1|1600|Roche Registration GmbH, Германия|3763.63|3|1|0|C||3||0|2.425036| L01BC59|TRIFLURIDINE/TIPIRACIL|LH459|Lonsurf|TABL. FILM. COAT.|15mg/6.14mg|MG|20|300|Les Laboratoires Servier, Франция|1173.77|4|0|0|C|3|1||0|3.81356| L01CD02|DOCETAXEL|LH460|Docetaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|160 mg/ 8 ml|mg|1|160|Accord Healthcare S.L.U., Испания|66.47|1|2|0|C||1||1|0.293046| L01BC59|TRIFLURIDINE/TIPIRACIL|LH461|Lonsurf|TABL. FILM. COAT.|20mg/8.19mg|MG|20|400|Les Laboratoires Servier, Франция|1560.5|4|0|0|C|3|1||0|3.81231| L01XA03|OXALIPLATIN|LH463|Oxaliplatin Bulgermed VE|CONCENTRATE FOR SOLUTION FOR INFUSION|5 MG/ML - 40 ML|mg|1|200|Булгермед ВЕ ООД, България|60.88|1|3|0|C||1||1|0.235699| L01XC24|DARATUMUMAB|LH464|DARZALEX|CONCENTRATE FOR SOLUTION FOR INFUSION|20 MG/ ML - 20ML|mg|1|400|Janssen-Cilag International N.V., Белгия|3429.23|1|4|0|C||4||1|8.573075| L01XE36|ALECTINIB|LH465|Alecensa|CAPSULE, HARD|150 mg|mg|224|33600|Roche Registration GmbH, Германия|9869.39|4|0|0|C|3|3||0|0.305305| L01XX50|IXAZOMIB|LH466|Ninlaro|CAPSULE, HARD|2.3 mg|mg|3|6.9|Takeda Pharma A/S, Дания|5236.3|4|0|0|C|3|3||0|745.59| L01XX50|IXAZOMIB|LH467|Ninlaro|CAPSULE, HARD|3 mg|mg|3|9|Takeda Pharma A/S, Дания|6829.96|4|0|0|C|3|3||0|745.59| L01XX50|IXAZOMIB|LH468|Ninlaro|CAPSULE, HARD|4 mg|mg|3|12|Takeda Pharma A/S, Дания|9106.61|4|0|0|C|3|3||0|745.59| L01XC26|INOTUZUMAB OZOGAMICIN|LH469|BESPONSA|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|1 mg|mg|1|1|Pfizer Europe MA EEIG, Белгия|22040.12|1|4|0|C||4||1|22051.536| L01XC32|ATEZOLIZUMAB|LH470|Tecentriq|CONCENTRATE FOR SOLUTION FOR INFUSION|1200 mg - 20 ml|mg|1|1200|Roche Registration GmbH, Германия|7831.73|1|2|0|C||4||0|6.83778| L01XE10|EVEROLIMUS|LH471|Everolimus Mylan|TABL|5 mg|mg|30|150|Mylan Iraland Limited, Ирландия|1310.62|4|0|0|C|3|3||0|9.48| L01XE10|EVEROLIMUS|LH472|Everolimus Mylan|TABL|10 mg|mg|30|300|Mylan Iraland Limited, Ирландия|2621.24|4|0|0|C|3|3||0|9.48| L01XE10|EVEROLIMUS|LH473|Everolimus Teva|TABL|10 mg|mg|30|300|Teva B.V, Нидерландия|2621.24|4|0|0|C|3|3||0|9.48| L01XC03|TRASTUZUMAB|LH474|Trazimera|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|150 mg|MG|1|150|Pfizer Enterprises S.A.R.L., Люксембург|668.22|1|4|0|C||3||1|2.36377| L01XE01|IMATINIB|LH475|Meaxin|TABL. FILM. COAT.|100 mg|mg|120|12000|KRKA d.d., Словения|202.06|4|0|0|C|3|3||0|0.0129| L03AA13|PEGFILGRASTIM|LH476|Pelgraz|SOLUTION FOR INJECTION|10mg/ml-0.6 ml|mg|1|6|Accord Healthcare S.L.U., Испания|619.87|2|1|0|C|7|5||0|63.583241| L03AA13|PEGFILGRASTIM|LH477|Ziextenzo|SOLUTION FOR INJECTION|10mg/ml-0.6 ml|mg|1|6|Sandoz GmbH, Австрия|619.87|2|1|0|C|7|5||0|63.583241| L01XC03|TRASTUZUMAB|LH478|Ogivri|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|150 mg|MG|1|150|Mylan S.A.S., Франция|668.22|1|4|0|C||3||1|2.36377| L01XX45|CARFILZOMIB|LH479|Kyprolis|POWDER FOR SOLUTION FOR INFISION|10 mg|mg|1|10|Amgen Europe B.V., Нидерландия|368.64|1|4|0|C||3||1|37.126| L01XX45|CARFILZOMIB|LH480|Kyprolis|POWDER FOR SOLUTION FOR INFISION|30 mg|mg|1|30|Amgen Europe B.V., Нидерландия|1105.92|1|4|0|C||3||1|37.126| L03AA13|PEGFILGRASTIM|LH481|Pelmeg|SOL.FOR INJ|10mg/ml-0.6 ml|mg|1|6|Mundipharma Biologics S.L., Испания|619.87|2|1|0|C|7|5||0|63.583241| L01XE02|GEFITINIB|LH482|Gefitinib Teva|TABL. FILM. COAT.|250 mg|mg|30|7500|Teva B.V, Нидерландия|1707.59|4|0|0|C|3|3||0|0.089274| L01XX19|IRINOTECAN|LH483|Irinotecan Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|MG|1|100|Булгермед ВЕ ООД, България|29.88|1|3|0|C||1||1|0.222271| L01XX46|OLAPARIB|LH484|Lynparza|TABL. FILM. COAT.|150 mg|MG|56|8400|Astra Zeneca AB, Швеция|5829.61|4|0|0|C|3|3||0|| L01XX46|OLAPARIB|LH485|Lynparza|TABL. FILM. COAT.|100 mg|MG|56|5600|Astra Zeneca AB, Швеция|3885.02|4|0|0|C|3|3||0|| L01XE03|ERLOTINIB|LH486|Erlotinib Zentiva|TABL. FILM. COAT.|100 mg|MG|30|3000|Zentiva k.s., Чешка република|764.95|4|0|0|C|3|3||0|0.055206| L01XE03|ERLOTINIB|LH487|Erlotinib Zentiva|TABL. FILM. COAT.|150 mg|MG|30|4500|Zentiva k.s., Чешка република|1147.43|4|0|0|C|3|3||0|0.055206| L01XE02|GEFITINIB|LH488|Gefitinib Alvogen|TABL. FILM. COAT.|250 mg|mg|30|7500|Zentiva k.s., Чешка република|1707.59|4|0|0|C|3|3||0|0.089274| L01XC24|DARATUMUMAB|LH490|DARZALEX|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Janssen-Cilag International N.V., Белгия|857.31|1|4|0|C||4||1|8.573075| L01XC05|GEMTUZUMAB OZOGAMICIN|LH491|Mylotarg|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|5 mg|mg|1|5|Pfizer Europe MA EEIG, Белгия|15854.22|1|4|0|C||4||1|| L01XC28|DURVALUMAB|LH492|Imfinzi|CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg/ml - 10 ml|mg|1|500|Astra Zeneca AB, Швеция|5175.4|1|3|0|C||3||1|| L01XC28|DURVALUMAB|LH493|Imfinzi|CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg/ml - 2.4 ml|mg|1|120|Astra Zeneca AB, Швеция|1242.1|1|3|0|C||3||1|| L01XE25|TRAMETINIB|LH494|Mekinist|TABL. FILM. COAT.|2 mg|mg|30|60|Novartis Europharm Ltd., Ирландия|8264.81|4|0|0|C|3|3||0|| L01XE39|MIDOSTAURIN|LH495|Rydapt|CAPS. SOFT|25 mg|mg|112|2800|Novartis Europharm Ltd., Ирландия|27002.46|4|0|0|C|3|3||0|| L01XE42|RIBOCICLIB|LH496|Kisqali|TABL. FILM. COAT.|200 mg|mg|42|8400|Novartis Europharm Ltd., Ирландия|3589.86|4|0|0|C|3|3||0|| L01XE42|RIBOCICLIB|LH497|Kisqali|TABL. FILM. COAT.|200 mg|mg|21|4200|Novartis Europharm Ltd., Ирландия|1794.91|4|0|0|C|3|3||0|| L01XE38|COBIMETINIB|LH498|Cotellic|TABL. FILM. COAT.|20 mg|mg|63|1260|Roche Registration GmbH, Германия|11041.03|4|0|0|C|3|3||0|| L01BA04|PEMETREXED|LH500|Pemetrexed Novamed|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|500 mg|mg|1|500|Новамед Трейдинг ЕООД, България|1063.03|1|2|0|C|7|1||1|0.2046| L01CD02|DOCETAXEL|LH501|Docetaxel Novamed|CONCENTRATE FOR SOLUTION FOR INFUSION|20mg/ml-8ml|mg|1|160|Новамед Трейдинг ЕООД, България|66.47|1|2|0|C||1||1|0.293046| L01CD02|DOCETAXEL|LH502|Docetaxel Novamed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 4 ml|mg|1|80|Новамед Трейдинг ЕООД, България|33.24|1|2|0|C||1||1|0.293046| L01XX19|IRINOTECAN|LH503|IRINOTECAN NOVAMED|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Новамед Трейдинг ЕООД, България|29.88|1|3|0|C||1||1|0.222271| L01XC31|AVELUMAB|LH504|Bavencio|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 10 ml|mg|1|200|Merck Europe B.V., Нидерландия|1858.28|1|3|0|C||4||1|| L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH505|Bendamustine Sandoz|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|100 mg|mg|1|100|Sandoz d.d., Словения|179.77|1|4|0|C|6|1||1|1.572068| L01XE50|ABEMACICLIB|LH506|Verzenios|TABL. FILM. COAT.|150 mg|mg|42|6300|Eli Lilly Nederland B.V., Нидерландия|3863.94|4|0|0|C|3|3||0|| L01XE50|ABEMACICLIB|LH507|Verzenios|TABL. FILM. COAT.|100 mg|mg|42|4200|Eli Lilly Nederland B.V., Нидерландия|2575.96|4|0|0|C|3|3||0|| L01XE50|ABEMACICLIB|LH508|Verzenios|TABL. FILM. COAT.|50 mg|mg|42|2100|Eli Lilly Nederland B.V., Нидерландия|1287.98|4|0|0|C|3|3||0|| L01XX25|BEXAROTENE|LH509|Targretin|CAPSULE, SOFT|75 mg|mg|100|7500|Eisai GmbH, Германия|1469.02|4|0|0|C|3|3||0|| L01XE31|NINTEDANIB|LH510|Vargatef|CAPSULE, SOFT|150 mg|mg|60|9000|Boehringer Ingelheim International GmbH, Германия|3570.84|4|0|0|C|3|1||0|| L01XE31|NINTEDANIB|LH511|Vargatef|CAPSULE, SOFT|100 mg|mg|120|12000|Boehringer Ingelheim International GmbH, Германия|4761.14|4|0|0|C|3|1||0|| L01XX24|PEGASPARGASE|LH512|Oncaspar|POWD.FOR SOL. FOR INJ/INF|750 U/ml - 3750 U|IU|1|3750|Les Laboratoires Servier, Франция|3594.95|1|3|0|C||1||1|| L04AX04|LENALIDOMIDE|LH513|Lenalidomid Alvogen|CAPSULE, HARD|5 mg|mg|21|105|Алвоген Фарма Трейдинг Юръп ЕООД, България|716.55|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH514|Lenalidomid Alvogen|CAPSULE, HARD|10 mg|mg|21|210|Алвоген Фарма Трейдинг Юръп ЕООД, България|1433.1|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH515|Lenalidomid Alvogen|CAPSULE, HARD|25 mg|mg|21|525|Алвоген Фарма Трейдинг Юръп ЕООД, България|3582.74|4|0|0|C|3|1||0|| L01XE43|BRIGATINIB|LH516|Alunbrig|TABL. FILM. COAT.|90 mg|mg|7|630|Takeda Pharma A/S, Дания|1091.32|4|0|0|C|3|3||0|| L01XE43|BRIGATINIB|LH517|Alunbrig|TABL. FILM. COAT.|30 mg|mg|28|840|Takeda Pharma A/S, Дания|1455.09|4|0|0|C|3|3||0|| L01XE43|BRIGATINIB|LH518|Alunbrig|TABL. FILM. COAT.|90 mg|mg|28|2520|Takeda Pharma A/S, Дания|4365.27|4|0|0|C|3|3||0|| L01XE43|BRIGATINIB|LH519|Alunbrig|TABL. FILM. COAT.|180 mg|mg|28|5040|Takeda Pharma A/S, Дания|8730.53|4|0|0|C|3|3||0|| L04AX06|POMALIDOMIDE|LH520|Imnovid|CAPSULE, HARD|4 mg|mg|21|84|Celgene Europe B.V. Нидерландия|17041.13|4|0|0|C|3|1||0|| L02BB04|ENZALUTAMIDE|LH522|Xtandi|TABL. FILM. COAT.|40 mg|mg|112|4480|Astellas Pharma Europe B.V., Нидерландия|5869.04|4|0|0|C|3|2||0|1.36933| L01XC32|ATEZOLIZUMAB|LH523|Tecentriq|CONCENTRATE FOR SOLUTION FOR INFUSION|840mg - 14ml|mg|1|840|Roche Registration GmbH, Германия|5482.21|1|2|0|C||4||0|6.83778| L01CD01|PACLITAXEL|LH524|Pazenir|POWDER FOR DISPERSION FOR INFUSION|5mg/ml|mg|1|100|Ratiopharm GmbH, Германия|319.2|1|3|0|C||1||1|| L01XC03|TRASTUZUMAB|LH525|Ontruzant|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|150 mg|mg|1|150|Samsung Bioepis NL B.V., Нидерландия|668.22|1|4|0|C||3||1|2.36377| L01XE02|GEFITINIB|LH526|Gefitinib Pharmadvice|TABL. FILM. COAT.|250 mg|mg|30|7500|Фармадвайс ЕООД, България|1707.59|4|0|0|C|3|3||0|0.089274| L01XE43|BRIGATINIB|LH528|Alunbrig|TABL. FILM. COAT.|90 mg + 180 mg|mg|28|4410|Takeda Pharma A/S, Дания|7639.22|4|0|0|C|3|3||0|| L01BC05|GEMCITABINE|LH529|Gemsol|CONCENTRATE FOR SOLUTION FOR INFUSION|40 mg/ml - 25 ml|MG|1|1000|Ebewe Pharma GmbH. N.fg. KG, Австрия|39.1|1|4|0|C|8|1||1|0.031363| L01CD02|DOCETAXEL|LH530|Docetaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 4 ml|MG|1|80|Булгермед ВЕ ООД, България|33.24|1|2|0|C||1||1|0.293046| L01CD02|DOCETAXEL|LH531|Docetaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20mg/ml-8ml|MG|1|160|Булгермед ВЕ ООД, България|66.47|1|2|0|C||1||1|0.293046| L01BB07|NELARABINE|LH532|Atriance|SOL. FOR INF.|5 mg/ml - 50ml|mg|1|250|Novartis Europharm Ltd., Ирландия|582.79|1|4|0|C||1||1|2.26008| L01XA01|CISPLATIN|LH533|Cisplatin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg/ml - 50 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, Австрия|10.72|1|4|0|C||1||1|0.21408| L01XA03|OXALIPLATIN|LH534|Oxaliplatin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|Ebewe Pharma GmbH. N.fg. KG, Австрия|30.44|1|3|0|C||1||1|0.235699| L01XC07|BEVACIZUMAB|LH535|MVASI|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Amgen Technology (Ireland) UC, Ирландия|1438.13|1|4|0|C|8|3||1|5.09334| L01XC07|BEVACIZUMAB|LH536|MVASI|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Amgen Technology (Ireland) UC, Ирландия|365.84|1|4|0|C|8|3||1|5.09334| L01XE29|LENVATINIB|LH537|Lenvima|CAPSULE, HARD|4 mg|mg|30|120|Eisai GmbH, Германия|3221.52|4|0|0|C|3|3||0|| L01XC07|BEVACIZUMAB|LH538|Zirabev|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|MG|1|400|Pfizer Europe MA EEIG, Белгия|1438.13|1|4|0|C|8|3||1|5.09334| L01XC07|BEVACIZUMAB|LH539|Zirabev|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|MG|1|100|Pfizer Europe MA EEIG, Белгия|365.84|1|4|0|C|8|3||1|5.09334| L01XX19|IRINOTECAN|LH540|Onivyde pegylated liposomal|CONCENTRATE FOR DISPERSION FOR INFUSION|4.3 mg/ml - 10 ml|mg|1|43|Les Laboratoires Servier, Франция|1874.78|1|4|0|C|7|1||1|| L02BB05|APALUTAMIDE|LH541|Erleada|TABL. FILM. COAT.|60 mg|mg|120|7200|Janssen-Cilag International N.V., Белгия|6140.47|4|0|0|C|3|3||0|| L04AX04|LENALIDOMIDE|LH542|Lenalidomide Sandoz|CAPSULE, HARD|5 mg|mg|21|105|Sandoz d.d., Словения|716.55|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH543|Lenalidomide Sandoz|CAPSULE, HARD|10 mg|mg|21|210|Sandoz d.d., Словения|1433.1|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH544|Lenalidomide Sandoz|CAPSULE, HARD|25 mg|mg|21|525|Sandoz d.d., Словения|3582.74|4|0|0|C|3|1||0|| L01XC33|CEMIPLIMAB|LH545|Libtayo|CONCENTRATE FOR SOLUTION FOR INFUSION|350 mg|mg|1|350|Regeneron Ireland Designated Activity Company (DAC), Ирландия|12805.15|1|2|0|C|3|3||0|| L01XE54|GILTERITINIB|LH546|Xospata|TABL. FILM. COAT.|40 mg|mg|84|3360|Astellas Pharma Europe B.V., Нидерландия|36831.67|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH547|Lenalidomide Pharmascience|CAPSULE, HARD|25 mg|mg|21|525|Pharmascience International Ltd., Кипър|3582.74|4|0|0|C|3|1||0|| L01BA04|PEMETREXED|LH548|Pemetrexed Sandoz|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 20 ml|mg|1|500|Sandoz d.d., Словения|1063.03|1|2|0|C|7|1||1|0.2046| L01BA04|PEMETREXED|LH549|Pemetrexed Sandoz|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 40 ml|mg|1|1000|Sandoz d.d., Словения|2126.06|1|2|0|C|7|1||1|0.2046| L04AX04|LENALIDOMIDE|LH550|Lenalidomide Pharmascience|CAPSULE, HARD|5 mg|mg|21|105|Pharmascience International Ltd., Кипър|716.55|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH551|Lenalidomide Pharmascience|CAPSULE, HARD|10 mg|mg|21|210|Pharmascience International Ltd., Кипър|1433.1|4|0|0|C|3|1||0|| L01BC07|AZACITIDINE|LH552|Azacitidine Sandoz|POWD.SUSP|25mg/ml|mg|1|100|Sandoz d.d., Словения|207.48|3|1|0|C||1||1|7.2228| L01BC07|AZACITIDINE|LH553|Azacitidine Pharmascience|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 150 mg)|mg|1|150|Pharmascience International Ltd., Кипър|311.22|3|1|0|C||1||1|7.2228| L01BC07|AZACITIDINE|LH554|Azacitidine Pharmascience|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|Pharmascience International Ltd., Кипър|207.48|3|1|0|C||1||1|7.2228| L01XE05|SORAFENIB|LH555|Sorafenib Pharmascience|TABL. FILM. COAT.|200 mg|mg|112|22400|Pharmascience International Ltd., Кипър|2649.13|4|0|0|C|3|3||0|0.288151| L01XE05|SORAFENIB|LH556|Nexavar|TABL. FILM. COAT.|200 mg|mg|112|22400|Bayer AG, Германия|6493.54|4|0|0|C|3|3||0|0.288151| L01XE05|SORAFENIB|LH557|Sorafenib Zentiva|TABL. FILM. COAT.|200 mg|mg|112|22400|Zentiva k.s., Чешка република|2649.13|4|0|0|C|3|3||0|0.288151| L01XC07|BEVACIZUMAB|LH559|Alymsys|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Mabxience Research SL, Испания|365.84|1|3|0|C|8|3||1|5.09334| L01XC07|BEVACIZUMAB|LH560|Alymsys|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Mabxience Research SL, Испания|1438.13|1|3|0|C|8|3||1|5.09334| L04AX04|LENALIDOMIDE|LH561|Lenalidomide Krka d.d. Novo mesto|CAPSULE, HARD|5 mg|mg|21|105|KRKA d.d., Словения|716.55|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH562|Lenalidomide Krka d.d. Novo mesto|CAPSULE, HARD|10 mg|mg|21|210|KRKA d.d., Словения|1433.1|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH563|Lenalidomide Krka d.d. Novo mesto|CAPSULE, HARD|25 mg|mg|21|525|KRKA d.d., Словения|3582.74|4|0|0|C|3|1||0|| L01XE05|SORAFENIB|LH564|Sorafenib Teva|TABL. FILM. COAT.|200 mg|mg|112|22400|Teva B.V, Нидерландия|2649.13|4|0|0|C|3|3||0|0.288151| L01XE05|SORAFENIB|LH565|Sorafenib Sandoz|TABL. FILM. COAT.|200 mg|mg|112|22400|Sandoz d.d., Словения|2649.13|4|0|0|C|3|3||0|0.288151| L01XE05|SORAFENIB|LH566|Sorafenib Mylan|TABL. FILM. COAT.|200 mg|mg|112|22400|Mylan Iraland Limited, Ирландия|2649.13|4|0|0|C|3|3||0|0.288151| L04AX04|LENALIDOMIDE|LH567|Lenalidomide G.L.|CAPSULE, HARD|5 mg|mg|21|105|G.L. Pharma GmbH, Австрия|716.55|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH568|Lenalidomide G.L.|CAPSULE, HARD|10 mg|mg|21|210|G.L. Pharma GmbH, Австрия|1433.1|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH569|Lenalidomide G.L.|CAPSULE, HARD|25 mg|mg|21|525|G.L. Pharma GmbH, Австрия|3582.74|4|0|0|C|3|1||0|| L01BC07|AZACITIDINE|LH570|Gerodaza|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|G.L. Pharma GmbH, Австрия|207.48|3|1|0|C||1||1|7.2228| L01EX01|SUNITINIB|LH571|Suniticon|CAPSULE, HARD|50 mg|mg|30|1500|Фармаконс АД, България|6360.06|4|0|0|C|3|3||0|6.0984| L01EX01|SUNITINIB|LH572|Suniticon|CAPSULE, HARD|12.5 mg|mg|30|375|Фармаконс АД, България|1590.02|4|0|0|C|3|3||0|6.0984| L04AX04|LENALIDOMIDE|LH573|Lenalidomide Accord|CAPSULE, HARD|25 mg|mg|21|525|Accord Healthcare S.L.U., Испания|3582.74|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH574|Lenalidomide Accord|CAPSULE, HARD|10 mg|mg|21|210|Accord Healthcare S.L.U., Испания|1433.1|4|0|0|C|3|1||0|| L04AX04|LENALIDOMIDE|LH575|Lenalidomide Accord|CAPSULE, HARD|5 mg|mg|21|105|Accord Healthcare S.L.U., Испания|716.55|4|0|0|C|3|1||0|| M05BA08|ZOLEDRONIC ACID|MH012|Zoledronic acid Actavis|CONCENTRATE FOR SOLUTION FOR INFUSION|4mg/5ml|mg|1|4|Actavis Group PTC ehf., Исландия|22.91|1|4|0|C||6||0|4.53| M05BX04|Denosumab|MH017|Xgeva|sol. for inj.|120 mg/1.7ml|mg|1|120|Amgen Europe B.V., Нидерландия|564.95|3|1|0|C|8|6||0|4.739684| M05BA08|ZOLEDRONIC ACID|MH022|Zolendronic acid Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|4 MG/5 ML|mg|1|4|Accord Healthcare S.L.U., Испания|22.91|1|4|0|C||6||0|4.53| N02AA01|Morphine|NO572|MORPHINE SOPHARMA sol. inj. 20 mg/ml - 1 ml x 100|sol. inj.|20mg/ml-1ml|mg|100|2000|Софарма АД, България|144.77|2|0|1|C||||0|0.072386| N02AA05|Oxycodone|NO580|OXYCONTIN|modified-release tabl.|20|mg|50|1000|Mundipharma GmbH, Австрия|16.98|4|0|1|C||||0|0.015966| N02AA05|Oxycodone|NO581|OXYCONTIN|modified-release tabl.|80|mg|50|4000|Mundipharma GmbH, Австрия|67.93|4|0|1|C||||0|0.015966| N02AA05|Oxycodone|NO582|OXYCONTIN|modified-release tabl.|10|mg|50|500|Mundipharma GmbH, Австрия|8.5|4|0|1|C||||0|0.015966| N02AA05|Oxycodone|NO583|OXYCONTIN|modified-release tabl.|40|mg|50|2000|Mundipharma GmbH, Австрия|33.97|4|0|1|C||||0|0.015966| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO584|TARGIN|prolonged release tablets|5mg/2.5 mg|mg|50|250|Mundipharma GmbH, Австрия|17.7|4|0|1|C||||0|0.066612| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO585|TARGIN|prolonged release tablets|10mg/5mg|mg|50|500|Mundipharma GmbH, Австрия|35.46|4|0|1|C||||0|0.066612| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO586|TARGIN|prolonged release tablets|20mg/10 mg|mg|50|1000|Mundipharma GmbH, Австрия|70.87|4|0|1|C||||0|0.066612| N02AB02|Pethidine hydrochloride|NO588|LYDOL sol.for inj. 50 mg/ml- 2 ml x 10|solution for injection|50mg/ml-2ml|mg|10|1000|Софарма АД, България|12.89|2|0|1|C||||0|0.0168| N02AB02|Pethidine hydrochloride|NO589|LYDOL sol.for inj. 50 mg/ml- 2 ml x 50|solution for injection|50mg/ml-2 ml|mg|50|5000|Софарма АД, България|64.44|2|0|1|C||||0|0.0168| N02AB03|Fentanyl|NO590|Victanyl 75 micrograms/h transdermal patches x 5|transdermal patches|75 mcg/h|mcg|5|375|Actavis Group PTC ehf., Исландия|40.24|4|0|1|C||||0|0.107299| N02AB03|Fentanyl|NO592|Victanyl 50 micrograms/h transdermal patches x 5|transdermal patches|50 mcg/h|mcg|5|250|Actavis Group PTC ehf., Исландия|26.83|4|0|1|C||||0|0.107299| N02AB03|Fentanyl|NO593|Victanyl 100 micrograms/h transdermal patches x 5|transdermal patches|100 mcg/h|mcg|5|500|Actavis Group PTC ehf., Исландия|53.65|4|0|1|C||||0|0.107299| N02AA01|Morphine|NO597|MORPHINE SOPHARMA sol. inj. 20 mg/ml - 1 ml x 10|sol. inj.|20mg/ml-1ml|mg|10|200|Софарма АД, България|14.48|2|0|1|C||||0|0.072386| N02AA05|Oxycodone|NO600|Oxycodone Actavis|caps. hard|10|mg|50|500|Actavis Group PTC ehf., Исландия|8.5|4|0|1|C||||0|0.015966| N02AA05|Oxycodone|NO601|Oxycodone Actavis|caps. hard|20|mg|50|1000|Actavis Group PTC ehf., Исландия|16.98|4|0|1|C||||0|0.015966| N02AA55|Oxycodone hidrochloride/ Naloxone hidrochloride|NO603|TARGIN|prolong. release tabl.|40mg/20mg| mg|100|4000|Mundipharma GmbH, Австрия|283.52|4|0|1|C||||0|0.066612| N02AE01|Buprenorphine|NO604|Buprenorphin Actavis|transdermal patch|35 mcg/h|mcg|5|175|Actavis Group PTC ehf., Исландия|25.25|4|0|1|C||||0|0.144343| N02AE01|Buprenorphine|NO605|Buprenorphin Actavis|transdermal patch|52,5 mcg/h|mcg|5|262.5|Actavis Group PTC ehf., Исландия|37.88|4|0|1|C||||0|0.144343| N02AE01|Buprenorphine|NO606|Buprenorphin Actavis|transdermal patch|70 mcg/h|mcg|5|350|Actavis Group PTC ehf., Исландия|50.51|4|0|1|C||||0|0.144343| N02AA01|Morphine|NO610|Doltard|prolong release tabl.|30|mg|100|3000|Takeda Pharma A/S, Дания|21.37|4|0|1|C||||0|0.0071| N02AX02|Tramadol|NO611|TRAMADOL STADA|sol. for inj.| 50 mg/ml - 2 ml|mg|5|500|Stada Arzneimittel AG, Германия|4.88|2|0|1|C||||0|0.008712| N02AA05|Oxycodone hydrochloride|NO612|Oxycodone Actavis|prolonged-release tabl.|10|mg|50|500|Actavis Group PTC ehf., Исландия|8.5|4|0|1|C||||0|0.015966| N02AA05|Oxycodone hydrochloride|NO613|Oxycodone Actavis|prolonged-release tabl.|20|mg|50|1000|Actavis Group PTC ehf., Исландия|16.98|4|0|1|C||||0|0.015966| N02AA05|Oxycodone hydrochloride|NO614|Oxycodone Actavis|prolonged-release tabl.|40|mg|50|2000|Actavis Group PTC ehf., Исландия|33.97|4|0|1|C||||0|0.015966| N02AA05|Oxycodone hydrochloride|NO617|Oxylan|prolonged- release tablets|20|mg|50|1000|G.L. Pharma GmbH, Австрия|16.98|4|0|1|C||||0|0.015966| N02AA05|Oxycodone hydrochloride|NO618|Oxylan|prolonged- release tablets|40|mg|50|2000|G.L. Pharma GmbH, Австрия|33.97|4|0|1|C||||0|0.015966| N02AA05|Oxycodone hydrochloride|NO619|Oxylan|prolonged- release tablets|80|mg|50|4000|G.L. Pharma GmbH, Австрия|67.93|4|0|1|C||||0|0.015966| N02AB03|Fentanyl|NO621|Vellofent|Sublingual tablet|133 mcg|mcg|4|532|Анджелини Фарма България ЕООД, България|48.6|4|0|1|C||||0|0.096519| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO622|Adolax|TABL. RELEASE PROLONG|20mg/10mg|mg|60|1200|KRKA d.d., Словения|85.06|4|0|1|C||||0|0.066612| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO623|Adolax|TABL. RELEASE PROLONG|10 mg/ 5 mg|mg|60|600|KRKA d.d., Словения|42.53|4|0|1|C||||0|0.066612| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO624|Adolax|TABL. RELEASE PROLONG|40 mg/ 20 mg|mg|60|2400|KRKA d.d., Словения|170.12|4|0|1|C||||0|0.066612| N02AJ13|TRAMADOL/PARACETAMOL|NO625|Doreta|TABL. FILM. COAT.|37.5MG/325MG|mg|60|21750|KRKA d.d., Словения|10.99|4|0|1|C||||0|0.00043| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO627|Oxycodone/Naloxone Teva|TABL. RELEASE PROLONG|10mg/5mg|mg|50|500|Teva B.V, Нидерландия|35.46|4|0|1|C||||0|0.066612| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO628|Oxycodone/Naloxone Teva|TABL. RELEASE PROLONG|20mg/10mg|mg|50|1000|Teva B.V, Нидерландия|70.87|4|0|1|C||||0|0.066612| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO629|Geroxynal|TABL. RELEASE PROLONG|10 mg/5 mg|mg|50|500|G.L. Pharma GmbH, Австрия|35.46|4|0|1|C||||0|0.066612| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO630|Geroxynal|TABL. RELEASE PROLONG|20 mg/ 10 mg|mg|50|1000|G.L. Pharma GmbH, Австрия|70.87|4|0|1|C||||0|0.066612| N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO631|Geroxynal|TABL. RELEASE PROLONG|40 mg/ 20 mg|mg|50|2000|G.L. Pharma GmbH, Австрия|141.78|4|0|1|C||||0|0.066612| N02AJ13|TRAMADOL/PARACETAMOL|NO632|Paratramol|TABL. FILM. COAT.|37.5MG/325MG|mg|90|32625|Pharmaceutical Works Polpharma S.A., Полша|16.49|4|0|1|C||||0|0.00043| N02AA08|Dihydrocodeine|NP414|DHC Continus|modified-release tablets|90|mg|50|4500|Mundipharma GmbH, Австрия|29.08|4|0|1|C||||0|0.007208| N02AX02|Tramadol|NP415|TRAMALGIN sol.for inj. 50 mg/ml-2 ml x10|sol.for inj.|50 mg/ml-2 ml|mg|10|1000|Софарма АД, България|9.76|2|0|1|C||||0|0.008712| N02AX02|Tramadol|NP419|TRAMADOL STADA|caps. hard|50|mg|30|1500|Stada Arzneimittel AG, Германия|4.28|4|0|1|C||||0|0.002432| N02AX02|TRAMADOL|NP420|Tramalgin|CAPSULES|50 mg|mg|20|1000|Софарма АД, България|2.85|4|0|1|C||||0|0.002432| V03AC01|Deferoxamine|VH009|Desferal|powder for solution for injection|500|mg|10|5000|Novartis Pharma GmbH, Германия|53.58|1|4|0|C|1|||0|0.01039| V03AF03|CALCIUM FOLINATE|VH015|Bendafolin|SOL.FOR INJ|10mg/ml-100ml|mg|1|1000|Lyomark Pharma GmbH, Germany|120.18|1|0|0|C|0|1||1|0.1194| V03AF03|Calcium folinate|VH018|Calcium folinate Sandoz|Solution for injection/infusion|10 mg/ml-10 ml|mg|1|100|Sandoz d.d., Словения|12.04|1|0|0|C|0|1||1|0.1194| V03AF03|Calcium folinate|VH019|Calcium folinate Sandoz|Solution for injection/infusion|10 mg/ml-5 ml|mg|5|250|Sandoz d.d., Словения|30.06|1|0|0|C|0|1||1|0.1194| V03AC03|Deferasirox|VH020|Exjade|Film coated tablet|180|mg|30|5400|Novartis Europharm Ltd., Ирландия|674.95|4|0|0|C|3|||0|0.126358| V03AF01|Mesna|VH021|UROMITEXAN|SOLUTION FOR INJECTION|100 mg/ml - 4 ml|mg|15|6000|Екофарм Груп АД, България|127.51|1|4|0|C|10|1||1|0.048818| V03AC02|DEFERIPRONE|VH022|Deferiprone Lipomed|TABL. FILM. COAT.|500 mg|mg|100|50000|Lipomed GmbH, Germany|271.57|4|0|0|C|3|||0|0.007697|